Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Heidler, Felicita; Bopp, Tobias; Schwab, Matthias et al.

Infections and multiple sclerosis

FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE. 2024


Neerukonda, Manjusha; Curella, Valentina; Sielaff, Malte et al.

INFLUENCE OF PROCESSING OF WHEAT FLOURS ON THEIR PROINFLAMMATORY TLR4-ACTIVATING POTENTIAL BY ATIS

GASTROENTEROLOGY. Bd. 166. H. 5. 2024 S. S738-S739


Herhaus, Lina; Gestal-Mato, Uxia; Eapen, Vinay V. et al.

IRGQ-mediated autophagy in MHC class I quality control promotes tumor immune evasion

CELL. Bd. 187. H. 25. 2024


Garlapati, Venkata; Luo, Qi; Posma, Jens et al.

Macrophage-Expressed Coagulation Factor VII Promotes Adverse Cardiac Remodeling

CIRCULATION RESEARCH. Bd. 135. H. 8. 2024 S. 841-855



Backer, Ronald A.; Probst, Hans Christian; Clausen, Bjoern E.

Multiparameter Flow Cytometric Analysis of the Conventional and Monocyte-Derived DC Compartment in the Murine Spleen

VACCINES. Bd. 12. H. 11. 2024


Lutz, Raphael; Gruenschlaeger, Florian; Simon, Malte et al.

Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy

NATURE COMMUNICATIONS. Bd. 15. H. 1. 2024


Kechagioglou, Petros; Chakraborty, Debomita; Dupont, Camille et al.

Narazaciclib's differential targets and kinase inhibitory activity contribute to the enhanced inhibition of tumor growth in preclinical models

CANCER RESEARCH. Bd. 84. H. 9. 2024


Ziemssen, Tjalf; Groth, Marie; Ettle, Benjamin et al.

Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab

HUMAN VACCINES & IMMUNOTHERAPEUTICS. Bd. 20. H. 1. 2024


Klehmet, Juliane; Bopp, Tobias

Ofatumumab in the treatment of multiple sclerosis - A summary of preclinical and clinical data

FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE. 2024